Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation

28 Oct 2014

Abstract excerpt

Allogeneic hematopoietic stem cell transplantation is mainly indicated in bone marrow dysfunction related to blood diseases, but also in some rare diseases (adrenoleucodystrophy, mitochondrial neurogastrointestinal encephalomyopathy or MNGIE...). After decades, this treatment has proven to be efficient at the cost of numerous early and delayed side effects such as infection, graft-versus-host disease,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Childhood Cancer Survivors' Quality of Life
Share to Hematopoietic Stem Cell Transplantation
Share to Hyperglycemia and glycemic control in critically ill and hospitalized patients

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25496809
DOI: 10.1186/s13023-014-0162-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantationPMID 25496809Read ↗

Endocrine and Metabolic Disturbances in Survivors of Hematopoietic Stem Cell Transplantation in Childhood and AdolescenceSemantic proximity Read ↗

Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelinesSemantic proximity Read ↗

Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders.Semantic proximity Read ↗

Endocrine dysfunction in adrenoleukodystrophy.Semantic proximity Read ↗

Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition TherapySemantic proximity Read ↗

Recommendations of Russian Society for Hematopoietic Stem Cell Transplantation, Gene and Cell therapy for diagnosis and treatment of graft-versus-host diseaseSemantic proximity Read ↗

Long-term endocrine sequelae after hematopoietic stem cell transplantation in children and adolescentsSemantic proximity Read ↗

Mesenchymal Stem Cells and Their Derived Products in Ageing and DiseasesSemantic proximity Read ↗

Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy Care NetworkSemantic proximity Read ↗

Hypophosphatasia update: recent advances in diagnosis and treatment.Semantic proximity Read ↗

Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapiesSemantic proximity Read ↗

Hypophosphatasia: an overview of the disease and its treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.